Evidence map›Paper›PMID 39055581›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2024

May Measurement Month 2021: an analysis of blood pressure screening results from Nigeria.

Kolawole W Wahab, Bolade Dele-Ojo, Sara Ahmadi-Abhari, Njide Okubadejo, Augustine Odili, Akinyemi Aje, Patrick Idoko, Maruf Gbadamosi, Sani Abubakar, Adeseye Akintunde and 6 more

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. May Measurement Month 2022: an analysis of blood pressure screening results from Nigeria.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kolawole W WahabDepartment of Medicine, University of Ilorin, Ilorin 240001, Nigeria.
Bolade Dele-OjoDepartment of Medicine, Ekiti State University, Ado Ekiti, Nigeria.
Sara Ahmadi-AbhariDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Njide OkubadejoDepartment of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria.
Augustine OdiliDepartment of Medicine, University of Abuja, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-4564-1587
Akinyemi AjeDepartment of Medicine, University College Hospital, Ibadan, Nigeria.
Patrick IdokoDepartment of Medicine, Federal Medical Centre, Makurdi, Nigeria.
Maruf GbadamosiDepartment of Medicine, Federal Medical Centre, Katsina, Nigeria.
Sani AbubakarDepartment of Medicine, Ahmadu Bello University, Zaria, Nigeria.
Adeseye AkintundeDepartment of Medicine, Ladoke Akintola University Teaching Hospital, Ogbomoso, Nigeria.
Fred AigbeDepartment of Medicine, Delta State University Teaching Hospital, Oghara, Nigeria.
Muhammad MakusidiDepartment of Medicine, Usmanu Danfodiyo University, Sokoto, Nigeria.
Yakub NyandaitiDepartment of Medicine, University of Maiduguri, Maiduguri, Nigeria.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.ORCID https://orcid.org/0000-0002-6292-997X
Ayodele B OmotosoDepartment of Medicine, University of Ilorin, Ilorin 240001, Nigeria.
MMM21 Nigeria Collaborators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a need to constantly assess the awareness, treatment, and control of hypertension in Nigeria. This study determined the frequency of undiagnosed hypertension across the six geopolitical zones of Nigeria. We conducted an opportunistic screening of adults aged at least 18 years in the month of May 2021. Participants were recruited by trained volunteers using the May Measurement Month protocol. Blood pressure (BP) was measured using validated digital sphygmomanometers. We defined hypertension as systolic BP ≥ 140 and/or diastolic BP ≥ 90 mmHg and/or the use of BP-lowering medications. A total of 9361 participants (51.5% females) with a mean age of 40.7 ± 15.5 years were screened. Hypertension was present in 3192 (34.1%) of the participants. About half (1491, 46.7%) of the hypertensives were unaware of the diagnosis. Among the 3192 participants with hypertension, less than half (1540, 48.2%) were on antihypertensive medications, while only 36.4% of those on antihypertensive medications had their BP controlled (<140/90 mmHg). About one-third of Nigerians in this opportunistic screening had hypertension, with about half of them being unaware of their diagnosis while only about two out of every five on antihypertensive medications had controlled BP. Urgent health actions are needed in Nigeria to reduce the burden of hypertension and its complications.

Indexed as

Blood pressureControlHypertensionNigeriaScreeningTreatmentUnaware

Identifiers

PMID39055581
PMCPMC11267697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.